Man Group plc grew its holdings in shares of Global Medical REIT Inc. (NYSE:GMRE - Free Report) by 321.7% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 561,022 shares of the company's stock after acquiring an additional 427,987 shares during the quarter. Man Group plc owned about 0.84% of Global Medical REIT worth $4,331,000 as of its most recent SEC filing.
A number of other institutional investors also recently added to or reduced their stakes in the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in Global Medical REIT by 11.4% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 1,260,098 shares of the company's stock worth $9,728,000 after acquiring an additional 128,449 shares during the period. Deutsche Bank AG lifted its holdings in shares of Global Medical REIT by 13.0% in the fourth quarter. Deutsche Bank AG now owns 45,544 shares of the company's stock valued at $352,000 after buying an additional 5,223 shares during the period. Corton Capital Inc. acquired a new stake in shares of Global Medical REIT in the fourth quarter valued at $85,000. Brevan Howard Capital Management LP acquired a new stake in shares of Global Medical REIT in the fourth quarter valued at $118,000. Finally, Captrust Financial Advisors acquired a new stake in shares of Global Medical REIT in the fourth quarter valued at $151,000. Institutional investors and hedge funds own 57.52% of the company's stock.
Wall Street Analysts Forecast Growth
Several analysts have recently weighed in on the company. Robert W. Baird cut their price objective on Global Medical REIT from $10.00 to $9.00 and set a "neutral" rating for the company in a report on Thursday, May 8th. B. Riley assumed coverage on Global Medical REIT in a report on Thursday, April 3rd. They issued a "neutral" rating and a $9.00 price objective for the company.
Read Our Latest Stock Report on GMRE
Global Medical REIT Trading Down 5.1%
Shares of Global Medical REIT stock opened at $6.27 on Thursday. The company has a quick ratio of 0.28, a current ratio of 0.28 and a debt-to-equity ratio of 1.26. The firm has a market cap of $419.41 million, a price-to-earnings ratio of -313.44, a price-to-earnings-growth ratio of 1.43 and a beta of 1.23. The business has a fifty day simple moving average of $7.66 and a 200-day simple moving average of $8.09. Global Medical REIT Inc. has a fifty-two week low of $6.26 and a fifty-two week high of $10.46.
Global Medical REIT (NYSE:GMRE - Get Free Report) last announced its earnings results on Wednesday, May 7th. The company reported $0.22 EPS for the quarter, meeting the consensus estimate of $0.22. Global Medical REIT had a return on equity of 0.86% and a net margin of 3.23%. The business had revenue of $34.60 million during the quarter, compared to the consensus estimate of $35.49 million. On average, equities analysts forecast that Global Medical REIT Inc. will post 0.81 EPS for the current fiscal year.
Global Medical REIT Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Wednesday, April 9th. Stockholders of record on Friday, March 21st were issued a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a dividend yield of 13.39%. The ex-dividend date was Friday, March 21st. Global Medical REIT's dividend payout ratio is 2,800.00%.
Global Medical REIT Profile
(
Free Report)
Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.
Further Reading
Want to see what other hedge funds are holding GMRE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Global Medical REIT Inc. (NYSE:GMRE - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Global Medical REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Global Medical REIT wasn't on the list.
While Global Medical REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
